Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

Journal of Experimental Medicine

Volumn 199, Issue 7, 2004, Pages 971-979

  Viglietta, Vissia ^a   Baecher Allan, Clare ^a   Weiner, Howard L ^a   Hafler, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autoimmune disease; Autoreactive T cells; L selectin; Tolerance

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; L SELECTIN; MYELIN PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL CLONING; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY DISEASE; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE; WHITE MATTER;

ADULT; ANIMALS; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNIZATION; L-SELECTIN; MICE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; SELF TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 1842732224     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031579     Document Type: Article

References (28)

1. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
2. Kappler, J.W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell. 49:273-280.
3. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 101:455-458.
4. Shevach, E.M., R.S. McHugh, C.A. Piccirillo, and A.M. Thornton. 2001. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol. Rev. 182:58-67.
5. Sakaguchi, S., K. Fukuma, K. Kuribayashi, and T. Masuda. 1985. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161:72-87.
6. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
7. Suri-Payer, E., A.Z. Amar, A.M. Thornton, and E.M. Shevach. 1998. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212-1218.
8. Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431-440.
9. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
10. Powrie, F., S. Mauze, and R.L. Coffman. 1997. CD4+ T-cells in the regulation of inflammatory responses in the intestine. Res. Immunol. 148:576-581.
11. Baecher-Allan, C., J.A. Brown, G.J. Freeman, and D.A. Hafler. 2001. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253.
12. Stephens, L.A., C. Mottet, D. Mason, and F. Powrie, 2001. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31:1247-1254.
13. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303-1310.
14. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
15. Shevach, E.M. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423-449.
16. Martin, R., B. Gran, Y. Zhao, S. Markovic-Plese, B. Bielekova, A. Marques, M.H. Sung, B. Hemmer, R. Simon, H.F. McFarland, and C. Pinilla. 2001. Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease. J. Autoimmun. 16:187-192.
17. O'Connor, K.C., A. Bar-Or, and D.A. Hafler. 2001. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J. Clin. Immunol. 21:81-92.
18. Steinman, L., R. Martin, C. Bernard, P. Conlon, and J.R. Oksenberg. 2002. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25:491-505.
19. Scholz, C., K.T. Patton, D.E. Anderson, G.J. Freeman, and D.A. Hafler. 1998. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 160:1532-1538.
20. Viglietta, V., S.C. Kent, T. Orban, and D.A. Hafler. 2002. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J. Clin. Invest. 109:895-903.
21. Lovett-Racke, A.E., J.L. Trotter, J. Lauber, P.J. Perrin, C.H. June, and M.K. Racke. 1998. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J. Clin. Invest. 101:725-730.
22. Reijonen, H., E.J. Novak, S. Kochik, A. Heninger, A.W. Liu, W.W. Kwok, and G.T. Nepom. 2002. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes. 51:1375-1382.
23. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295-1302.
24. Baecher-Allan, C., V. Viglietta, and D.A. Hafler. 2002. Inhibition of human CD4(+)CD25(high) regulatory T cell function. J. Immunol. 169:6210-6217.
25. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036.
26. Kohm, A.P., P.A. Carpentier, H.A. Anger, and S.D. Miller. 2002. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169:4712-4716.
27. Szanya, V., J. Ermann, C. Taylor, C. Holness, and C.G. Fathman. 2002. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461-2465.
28. Kohm, A.P., and S.D. Miller. 2003. Role of ICAM-1 and P-selectin expression in the development and effector function of CD4+CD25+ regulatory T cells. J. Autoimmun. 21:261-271.